Certified by Founder Lodge
ATEM Capital
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $100,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ATEM Capital manages evergreen Life Sciences investment fund - Health Square Fund (HSF). HSF acts as a consolidator of capital flows from the Emerging Markets and invests into the biotech inn
| Company | Date | Round | Raised |
|---|---|---|---|
Triumvira Immunologics, Inc. |
March, 17 ,2022 | Series A | $100,000,000 |
Triumvira Immunologics, Inc.
dezerv.
FalconX
Kristal.AI
Finary
Savart
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)